Alexandre Prat

29.9k total citations · 6 hit papers
209 papers, 16.2k citations indexed

About

Alexandre Prat is a scholar working on Immunology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Alexandre Prat has authored 209 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Immunology, 94 papers in Neurology and 73 papers in Pathology and Forensic Medicine. Recurrent topics in Alexandre Prat's work include Neuroinflammation and Neurodegeneration Mechanisms (73 papers), Multiple Sclerosis Research Studies (72 papers) and Barrier Structure and Function Studies (38 papers). Alexandre Prat is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (73 papers), Multiple Sclerosis Research Studies (72 papers) and Barrier Structure and Function Studies (38 papers). Alexandre Prat collaborates with scholars based in Canada, United States and Germany. Alexandre Prat's co-authors include Richard Daneman, Jack P. Antel, Jorge I. Alvarez, Hania Kébir, Romain Cayrol, Nathalie Arbour, Burkhard Becher, Igal Ifergan, Monique Bernard and Aurore Dodelet-Devillers and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Alexandre Prat

203 papers receiving 16.0k citations

Hit Papers

The Blood–Brain Barrier 2007 2026 2013 2019 2015 2007 2011 2016 2013 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Blood–Brain Barrier
    2015 2.3k citations Alexandre Prat et al. profile →
  2. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
    2007 1.4k citations Hania Kébir, Igal Ifergan et al. Nature Medicine profile →
  3. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
    2011 641 citations Jorge I. Alvarez, Aurore Dodelet-Devillers et al. profile →
  4. An updated histological classification system for multiple sclerosis lesions
    2016 454 citations Alexandre Prat, Jack P. Antel et al. profile →
  5. Glial influence on the blood brain barrier
    2013 419 citations Jorge I. Alvarez, Alexandre Prat et al. profile →
  6. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes
    2021 214 citations Stéphanie Zandee, Burkhard Becher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Prat Canada 61 5.9k 5.1k 4.6k 3.7k 2.0k 209 16.2k
Helga E. de Vries Netherlands 74 5.5k 0.9× 3.0k 0.6× 6.2k 1.3× 2.5k 0.7× 1.8k 0.9× 257 16.8k
Jan Bauer Austria 68 3.7k 0.6× 4.1k 0.8× 3.4k 0.7× 4.1k 1.1× 1.4k 0.7× 221 14.5k
Sandra Amor Netherlands 61 4.3k 0.7× 3.9k 0.8× 3.6k 0.8× 3.1k 0.8× 995 0.5× 198 12.4k
Francesca Aloisi Italy 62 5.2k 0.9× 6.7k 1.3× 3.2k 0.7× 5.1k 1.4× 2.5k 1.2× 130 15.9k
Celia F. Brosnan United States 70 5.9k 1.0× 6.3k 1.2× 4.7k 1.0× 2.3k 0.6× 1.9k 0.9× 205 16.7k
Paul van der Valk Netherlands 80 4.3k 0.7× 3.3k 0.6× 5.8k 1.2× 5.6k 1.5× 5.4k 2.7× 252 19.5k
Etty Benveniste United States 80 5.2k 0.9× 7.5k 1.5× 6.0k 1.3× 1.5k 0.4× 3.8k 1.9× 233 18.5k
Harald Neumann Germany 63 7.0k 1.2× 4.9k 1.0× 3.3k 0.7× 1.3k 0.4× 934 0.5× 189 13.6k
Sven G. Meuth Germany 59 2.6k 0.4× 2.7k 0.5× 4.1k 0.9× 3.1k 0.8× 1.3k 0.6× 561 14.0k
Burkhard Becher Switzerland 80 7.2k 1.2× 15.3k 3.0× 6.2k 1.3× 3.4k 0.9× 3.8k 1.9× 234 27.0k

Countries citing papers authored by Alexandre Prat

Since Specialization
Citations

This map shows the geographic impact of Alexandre Prat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Prat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Prat more than expected).

Fields of papers citing papers by Alexandre Prat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Prat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Prat. The network helps show where Alexandre Prat may publish in the future.

Co-authorship network of co-authors of Alexandre Prat

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Prat. A scholar is included among the top collaborators of Alexandre Prat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Prat. Alexandre Prat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lozinski, Brian M., Samira Ghorbani, Yifei Dong, et al.. (2025). Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models. Neurology Neuroimmunology & Neuroinflammation. 12(4). e200413–e200413.
2.
Wong, Vincent Kam Wai, Moein Yaqubi, Craig S. Moore, et al.. (2025). Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis. Brain.
3.
Shiga, Yukihiro, Nicolás Belforte, Olivier Tastet, et al.. (2024). Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma. Science Advances. 10(32). eadl5722–eadl5722. 9 indexed citations
4.
Butzkueven, Helmut, Tomáš Kalinčík, Francesco Patti, et al.. (2024). Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic Advances in Neurological Disorders. 17. 4223502419–4223502419. 2 indexed citations
5.
Drake, Sienna, Wendy Klément, Jo Anne Stratton, et al.. (2024). Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 21(1). 283–283. 15 indexed citations
6.
Macaron, Gabrielle, et al.. (2023). Impact of aging on treatment considerations for multiple sclerosis patients. Frontiers in Neurology. 14. 1197212–1197212. 25 indexed citations
7.
8.
Dubé, Mathieu, Olivier Tastet, Caroline Dufour, et al.. (2023). Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells. Cell Host & Microbe. 31(9). 1507–1522.e5. 33 indexed citations
9.
10.
Dong, Yifei, Charlotte D’Mello, William W. Pinsky, et al.. (2021). Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nature Neuroscience. 24(4). 489–503. 118 indexed citations
11.
Stefano, Nicola De, Frederik Barkhof, Xavier Montalbán, et al.. (2021). Reduction in CUA MRI Lesions in the First 6 Months after Cladribine Tablets Treatment for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS Subgroup Analysis (1921). Neurology. 96(15_supplement). 1 indexed citations
12.
Michel, Laure, Camille Grasmuck, Marc Charabati, et al.. (2019). Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers. Science Translational Medicine. 11(518). 47 indexed citations
13.
Ayrignac, Xavier, Philippe‐Antoine Bilodeau, Alexandre Prat, et al.. (2019). Assessing the risk of multiple sclerosis disease-modifying therapies. Expert Review of Neurotherapeutics. 19(7). 695–706. 8 indexed citations
14.
Luo, Hongyu, Bieke Broux, Xuehai Wang, et al.. (2016). EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurobiology of Disease. 91. 292–306. 19 indexed citations
15.
Pittet, Camille L., et al.. (2015). An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry. Journal of Neuroscience Methods. 247. 23–31. 39 indexed citations
16.
Zhang, Monan Angela, Hania Kébir, Andrzej Chruscinski, et al.. (2012). Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proceedings of the National Academy of Sciences. 109(24). 9505–9510. 170 indexed citations
17.
Schulze‐Topphoff, Ulf, Alexandre Prat, Timour Prozorovski, et al.. (2009). Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nature Medicine. 15(7). 788–793. 97 indexed citations
18.
Wosik, Karolina, Romain Cayrol, Aurore Dodelet-Devillers, et al.. (2007). Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis. Journal of Neuroscience. 27(34). 9032–9042. 201 indexed citations
19.
Qin, Yufen, et al.. (2000). Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients. Journal of Neuroimmunology. 108(1-2). 201–206. 60 indexed citations
20.
Prat, Alexandre, Katarzyna Biernacki, Burkhard Becher, & Jack P. Antel. (2000). B7 Expression and Antigen Presentation by Human Brain Endothelial Cells: Requirement for Proinflammatory Cytokines. Journal of Neuropathology & Experimental Neurology. 59(2). 129–136. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helga E. de Vries Breakdown of academic impact, for papers by Jan Bauer Breakdown of academic impact, for papers by Sandra Amor Breakdown of academic impact, for papers by Francesca Aloisi Breakdown of academic impact, for papers by Celia F. Brosnan Breakdown of academic impact, for papers by Paul van der Valk Breakdown of academic impact, for papers by Etty Benveniste Breakdown of academic impact, for papers by Harald Neumann Breakdown of academic impact, for papers by Sven G. Meuth Breakdown of academic impact, for papers by Burkhard Becher
Rankless by CCL
2026